IMMUNDEFIZIENTE NAGER

Patent europeic · EP3950949 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3950949
Numer da la dumonda
EP20776454
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
26-03-2020
Publitgà
09-02-2022
Concedì
04-12-2024
La protecziun finescha il pli tard
25-03-2040
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
C12N 15/877 (2010.01)
A01K 67/027 (2024.01)
C12N 5/0789 (2010.01)
C12N 15/24 (2006.01)
C12N 15/27 (2006.01)
Prioritad
JP 2019062919 28.03.2019
Dumonda PCT
PCT/JP2020/013635 26.03.2020
Publicaziun PCT
WO2020/196742 01.10.2020
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 15-10-2025

    Midada

    Published in Swissreg on 15.10.2025

  3. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  4. 04-12-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.12.2024

Partidas

Possessur

Central Institute for Experimental Medicine and Life Science

3-25-12, Tonomachi Kawasaki-ku, Kawasaki-shi, Kanagawa 210-0821, JP

Inventur

ITO, Ryoji

Kawasaki-shi, Kanagawa 210-0821, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.